Pathway Total Expectd Hits P.Value FDR
Cellular senescence 160 11.8 33 4.00E-08 1.27E-05
HTLV-I infection 219 16.1 38 4.51E-07 6.97E-05
FoxO signaling pathway 132 9.71 27 8.29E-07 6.97E-05
TNF signaling pathway 110 8.09 24 1.00E-06 6.97E-05
Chagas disease (American trypanosomiasis) 103 7.57 23 1.10E-06 6.97E-05
Kaposi’s sarcoma-associated herpesvirus infection 186 13.7 33 1.57E-06 8.32E-05
Pathways in cancer 530 39 67 5.56E-06 0.000253
Renal cell carcinoma 69 5.07 17 6.86E-06 0.000273
Colorectal cancer 86 6.32 18 4.10E-05 0.00138
Complement and coagulation cascades 79 5.81 17 4.60E-05 0.00138
p53 signaling pathway 72 5.3 16 5.06E-05 0.00138
Apelin signaling pathway 137 10.1 24 5.19E-05 0.00138
Insulin resistance 108 7.94 20 9.79E-05 0.00239
MAPK signaling pathway 295 21.7 40 0.000105 0.00239
mTOR signaling pathway 153 11.3 25 0.000118 0.00239
IL-17 signaling pathway 93 6.84 18 0.00012 0.00239
Hepatitis B 163 12 26 0.000131 0.00245
cAMP signaling pathway 212 15.6 31 0.000161 0.00285
cGMP-PKG signaling pathway 166 12.2 26 0.000177 0.00297
Circadian rhythm 31 2.28 9 0.000274 0.00436
Oxytocin signaling pathway 153 11.3 24 0.000305 0.00451
AGE-RAGE signaling pathway in diabetic complications 100 7.35 18 0.000312 0.00451
Proteoglycans in cancer 201 14.8 29 0.000329 0.00455
Chronic myeloid leukemia 76 5.59 15 0.00035 0.00464
Sphingolipid signaling pathway 119 8.75 20 0.000382 0.00485
Breast cancer 147 10.8 23 0.00042 0.00514
B cell receptor signaling pathway 71 5.22 14 0.000553 0.00651
Prostate cancer 97 7.13 17 0.000627 0.00691
Melanoma 72 5.3 14 0.000641 0.00691
Platelet activation 124 9.12 20 0.000661 0.00691
Longevity regulating pathway 89 6.55 16 0.000673 0.00691
Mitophagy - animal 65 4.78 13 0.00075 0.00746
Ras signaling pathway 232 17.1 31 8.00E-04 0.00771
Rheumatoid arthritis 91 6.69 16 0.000866 0.008
Apoptosis 136 10 21 0.000881 0.008
Pancreatic cancer 75 5.52 14 0.00098 0.00842
Glioma 75 5.52 14 0.00098 0.00842
Neurotrophin signaling pathway 119 8.75 19 0.00101 0.00848
Small cell lung cancer 93 6.84 16 0.0011 0.00892
Pertussis 76 5.59 14 0.00112 0.00892
Epithelial cell signaling in Helicobacter pylori infection 68 5 13 0.00117 0.00907
Legionellosis 55 4.04 11 0.00188 0.014
Th17 cell differentiation 107 7.87 17 0.00194 0.014
Regulation of actin cytoskeleton 214 15.7 28 0.00194 0.014
Phosphatidylinositol signaling system 99 7.28 16 0.00217 0.015
Choline metabolism in cancer 99 7.28 16 0.00217 0.015
Rap1 signaling pathway 206 15.1 27 0.00226 0.0153
Insulin signaling pathway 137 10.1 20 0.00232 0.0154
Non-small cell lung cancer 66 4.85 12 0.00279 0.018
Focal adhesion 199 14.6 26 0.00283 0.018
Endometrial cancer 58 4.27 11 0.00293 0.0183
Chemokine signaling pathway 190 14 25 0.00308 0.0188
Prion diseases 35 2.57 8 0.00324 0.0195
ErbB signaling pathway 85 6.25 14 0.00336 0.0198
Salmonella infection 86 6.32 14 0.00376 0.0217
Adipocytokine signaling pathway 69 5.07 12 0.00408 0.023
Amoebiasis 96 7.06 15 0.00412 0.023
EGFR tyrosine kinase inhibitor resistance 79 5.81 13 0.00468 0.0256
Cytokine-cytokine receptor interaction 294 21.6 34 0.00532 0.0287
Wnt signaling pathway 158 11.6 21 0.00569 0.0297
Measles 138 10.1 19 0.00569 0.0297
HIF-1 signaling pathway 100 7.35 15 0.00607 0.0306
Inflammatory mediator regulation of TRP channels 100 7.35 15 0.00607 0.0306
Fluid shear stress and atherosclerosis 139 10.2 19 0.00615 0.0306
PI3K-Akt signaling pathway 354 26 39 0.00673 0.0329
Cholinergic synapse 112 8.24 16 0.00754 0.0362
GnRH signaling pathway 93 6.84 14 0.00764 0.0362
Vascular smooth muscle contraction 132 9.71 18 0.00774 0.0362
Glucagon signaling pathway 103 7.57 15 0.00799 0.0368
Malaria 49 3.6 9 0.00853 0.0387
Fc epsilon RI signaling pathway 68 5 11 0.0101 0.0448
Amphetamine addiction 68 5 11 0.0101 0.0448
Pantothenate and CoA biosynthesis 19 1.4 5 0.0103 0.045
Aldosterone synthesis and secretion 98 7.21 14 0.012 0.0505
Estrogen signaling pathway 138 10.1 18 0.0121 0.0505
Autophagy - animal 128 9.41 17 0.0122 0.0505
Osteoclast differentiation 128 9.41 17 0.0122 0.0505
Prolactin signaling pathway 70 5.15 11 0.0125 0.0511
Signaling pathways regulating pluripotency of stem cells 139 10.2 18 0.013 0.0522
Axon guidance 181 13.3 22 0.0132 0.0524
Longevity regulating pathway - multiple species 62 4.56 10 0.0142 0.0554
AMPK signaling pathway 120 8.83 16 0.0143 0.0554
T cell receptor signaling pathway 101 7.43 14 0.0154 0.0584
Melanogenesis 101 7.43 14 0.0154 0.0584
Thyroid cancer 37 2.72 7 0.0166 0.0623
Transcriptional misregulation in cancer 186 13.7 22 0.0177 0.0654
Leishmaniasis 74 5.44 11 0.0186 0.068
Adrenergic signaling in cardiomyocytes 145 10.7 18 0.0194 0.0694
Central carbon metabolism in cancer 65 4.78 10 0.0194 0.0694
Epstein-Barr virus infection 201 14.8 23 0.0222 0.0783
Phospholipase D signaling pathway 148 10.9 18 0.0234 0.0817
Hematopoietic cell lineage 97 7.13 13 0.0247 0.0855
Gap junction 88 6.47 12 0.0268 0.0917
Bladder cancer 41 3.02 7 0.0282 0.0955
Progesterone-mediated oocyte maturation 99 7.28 13 0.0287 0.0962
Dopaminergic synapse 131 9.63 16 0.0303 0.1
NF-kappa B signaling pathway 100 7.35 13 0.0309 0.101
Hippo signaling pathway 154 11.3 18 0.0332 0.108
Leukocyte transendothelial migration 112 8.24 14 0.0346 0.111
Fatty acid biosynthesis 18 1.32 4 0.0387 0.123
Platinum drug resistance 73 5.37 10 0.04 0.126
Toll-like receptor signaling pathway 104 7.65 13 0.0408 0.127
Thyroid hormone signaling pathway 116 8.53 14 0.0447 0.138
Non-alcoholic fatty liver disease (NAFLD) 149 11 17 0.046 0.14
Hypertrophic cardiomyopathy (HCM) 85 6.25 11 0.0461 0.14
Shigellosis 65 4.78 9 0.0471 0.141